1075 biotinylated maa ii vector laboratories Search Results


95
Vector Laboratories vva b 1235 2 pna b 1075 5
Vva B 1235 2 Pna B 1075 5, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Biotinylated+Vicia+Villosa+Lectin+(VVL%2C+VVA)/bio_rxiv__2024__05__09__593410-164-11-9
Average 95 stars, based on 1 article reviews
vva b 1235 2 pna b 1075 5 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
Vector Laboratories biotinylated peanut lectin agglutinin pna
Biotinylated Peanut Lectin Agglutinin Pna, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Biotinylated+Peanut+Agglutinin+(PNA)/pm16887989-64-14-19
Average 95 stars, based on 1 article reviews
biotinylated peanut lectin agglutinin pna - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Vector Laboratories ulex europaeus agglutinin uea
The principal carbohydrate patterns recognized by the 4 lectins tested.
Ulex Europaeus Agglutinin Uea, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Biotinylated+Concanavalin+A+(Con+A)/pmc10593828-274-30-40
Average 94 stars, based on 1 article reviews
ulex europaeus agglutinin uea - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
Vector Laboratories biotin conjugated peanut agglutinin
The principal carbohydrate patterns recognized by the 4 lectins tested.
Biotin Conjugated Peanut Agglutinin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Unconjugated+Peanut+Agglutinin+(PNA)/pm16293577-56-13-19
Average 95 stars, based on 1 article reviews
biotin conjugated peanut agglutinin - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

93
vector laboratories b-1075
The principal carbohydrate patterns recognized by the 4 lectins tested.
B 1075, supplied by vector laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Biotinylated+Anti-Peanut+Agglutinin+(PNA)/pmc12428710-2-0-3
Average 93 stars, based on 1 article reviews
b-1075 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
Vector Laboratories pna
The principal carbohydrate patterns recognized by the 4 lectins tested.
Pna, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Fluorescein+labeled+Peanut+Agglutinin+(PNA)/pmc06879515-215-14-16
Average 95 stars, based on 1 article reviews
pna - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

99
Vector Laboratories biotinylated peanut agglutinin
The principal carbohydrate patterns recognized by the 4 lectins tested.
Biotinylated Peanut Agglutinin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Streptavidin/pmc03696004-113-3-6
Average 99 stars, based on 1 article reviews
biotinylated peanut agglutinin - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

96
Vector Laboratories biotinylated lectins
(A) Representative histograms from flow cytometry analysis of CTB- (red) and OVA- (white) binding to cell types in human peripheral blood. (B) Bar graphs show the geometric mean fluorescent index (gMFI) of CTB binding (with OVA gMFI subtracted) to human whole blood (n = 8) and murine splenocytes (n = 4–6). Each dot represents one donor/mouse. (C) gMFI of CTB and OVA binding to the different cell types from human whole blood. Each pair of dots represents one donor. (D-E) Histogram and bar graph (n = 8) showing blocking of CTB binding to human granulocytes by pre-treating CTB with (D) L-, D-fucose and D-galactose or (E) with the <t>lectins</t> AAL or MAL-II. (F) Histograms and bar graphs (n = 6) showing the blocking of CTB binding to murine (wt or KO) cells by either pre-treating the cells with lectins or pre-treating CTB with sugars. For panel (C) significance was calculated using paired t-test and for (D-E) one-way-ANOVA was used with Tukey correction (*** = p<0,005, **** = p<0,0001).
Biotinylated Lectins, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Biotinylated+Maackia+Amurensis+Lectin+II+(MAL+II)/pmc05825173-377-20-22
Average 96 stars, based on 1 article reviews
biotinylated lectins - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Vector Laboratories cy5
(A) Representative histograms from flow cytometry analysis of CTB- (red) and OVA- (white) binding to cell types in human peripheral blood. (B) Bar graphs show the geometric mean fluorescent index (gMFI) of CTB binding (with OVA gMFI subtracted) to human whole blood (n = 8) and murine splenocytes (n = 4–6). Each dot represents one donor/mouse. (C) gMFI of CTB and OVA binding to the different cell types from human whole blood. Each pair of dots represents one donor. (D-E) Histogram and bar graph (n = 8) showing blocking of CTB binding to human granulocytes by pre-treating CTB with (D) L-, D-fucose and D-galactose or (E) with the <t>lectins</t> AAL or MAL-II. (F) Histograms and bar graphs (n = 6) showing the blocking of CTB binding to murine (wt or KO) cells by either pre-treating the cells with lectins or pre-treating CTB with sugars. For panel (C) significance was calculated using paired t-test and for (D-E) one-way-ANOVA was used with Tukey correction (*** = p<0,005, **** = p<0,0001).
Cy5, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Cy5+labeled+Peanut+Agglutinin+(PNA)/bio_rxiv__623918-48-30-47
Average 94 stars, based on 1 article reviews
cy5 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Vector Laboratories n acetylgalactosamine
List of names and specifications of antibodies and lectins used in this work
N Acetylgalactosamine, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/N-acetylgalactosamine/pmc07219290-7-3-8
Average 93 stars, based on 1 article reviews
n acetylgalactosamine - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
Vector Laboratories biotinylated sna
List of names and specifications of antibodies and lectins used in this work
Biotinylated Sna, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1075+biotinylated+maa+ii+vector+laboratories/Biotinylated+Sambucus+Nigra+Lectin+(SNA%2C+EBL)/pmc08553859-370-15-17
Average 96 stars, based on 1 article reviews
biotinylated sna - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


The principal carbohydrate patterns recognized by the 4 lectins tested.

Journal: Scientific Reports

Article Title: Targeting cell-derived markers to improve the detection of invisible biological traces for the purpose of genetic-based criminal identification

doi: 10.1038/s41598-023-45366-y

Figure Lengend Snippet: The principal carbohydrate patterns recognized by the 4 lectins tested.

Article Snippet: Samples were incubated for 20 min in a humidity chamber using a biotinylated lectin solution (at final concentration 10 µg/ml): Concanavalin A (ConA), Peanut agglutinin (PNA), Elderberry lectin (SNA), and Ulex europaeus agglutinin (UEA) (B-1005, B-1075, B-1305, and B-1065 respectively, Vector Laboratories, USA).

Techniques:

(A) Representative histograms from flow cytometry analysis of CTB- (red) and OVA- (white) binding to cell types in human peripheral blood. (B) Bar graphs show the geometric mean fluorescent index (gMFI) of CTB binding (with OVA gMFI subtracted) to human whole blood (n = 8) and murine splenocytes (n = 4–6). Each dot represents one donor/mouse. (C) gMFI of CTB and OVA binding to the different cell types from human whole blood. Each pair of dots represents one donor. (D-E) Histogram and bar graph (n = 8) showing blocking of CTB binding to human granulocytes by pre-treating CTB with (D) L-, D-fucose and D-galactose or (E) with the lectins AAL or MAL-II. (F) Histograms and bar graphs (n = 6) showing the blocking of CTB binding to murine (wt or KO) cells by either pre-treating the cells with lectins or pre-treating CTB with sugars. For panel (C) significance was calculated using paired t-test and for (D-E) one-way-ANOVA was used with Tukey correction (*** = p<0,005, **** = p<0,0001).

Journal: PLoS Pathogens

Article Title: GM1 ganglioside-independent intoxication by Cholera toxin

doi: 10.1371/journal.ppat.1006862

Figure Lengend Snippet: (A) Representative histograms from flow cytometry analysis of CTB- (red) and OVA- (white) binding to cell types in human peripheral blood. (B) Bar graphs show the geometric mean fluorescent index (gMFI) of CTB binding (with OVA gMFI subtracted) to human whole blood (n = 8) and murine splenocytes (n = 4–6). Each dot represents one donor/mouse. (C) gMFI of CTB and OVA binding to the different cell types from human whole blood. Each pair of dots represents one donor. (D-E) Histogram and bar graph (n = 8) showing blocking of CTB binding to human granulocytes by pre-treating CTB with (D) L-, D-fucose and D-galactose or (E) with the lectins AAL or MAL-II. (F) Histograms and bar graphs (n = 6) showing the blocking of CTB binding to murine (wt or KO) cells by either pre-treating the cells with lectins or pre-treating CTB with sugars. For panel (C) significance was calculated using paired t-test and for (D-E) one-way-ANOVA was used with Tukey correction (*** = p<0,005, **** = p<0,0001).

Article Snippet: Cells were then incubated for 30 min on ice with diluted biotinylated CTB (Thermo Fisher Scientific/Invitrogen, Cat. No. C34779) or biotinylated lectins (Vector Labs: PNA, Cat. B-1075; MAL-II, Cat. No. B-1265; AAL, Cat. No. B-1395) at the following concentrations: 100 μl of 10 μg/ml was added per well.

Techniques: Flow Cytometry, Binding Assay, Blocking Assay

(A) Bar graph showing relative absorbance values from an ELISA with immobilized anti-Le X , and detection with CTB-HRP. Samples as indicated from lysates of isolated human cells (2 μg protein/ml). Each dot represents a human donor (n = 5–8). (B) CD66 or (C) CD66 and Le X expression by jejunal epithelial cells that were isolated using EDTA medium (villi) or enzymatic degradation after EDTA treatment (non-villi or crypt). Histograms from flow cytometry analyses of CTB-, G33D- and OVA-binding to the differentially enriched epithelial cells. (B) EpCAM + cells and (C) EpCAM + Le X+ cells. (D-G) Bar graph showing percent of gMFI of CTB binding to jejunal epithelial cells by pretreatment of the cells with (D) lectins, (E) sugars, (F) oligosaccharides and (G) HSA-linked oligosaccharides. Graphs show the percent of gMFI of CTB binding to the cells where 100% represents CTB staining with no blocking oligosaccharide. Each dot represents a donor in (D) n = 4–12, (E) n = 6–8, (F) n = 6–12, (G) n = 6–7. Significance was calculated using a one-way-ANOVA with Tukey correction compared to CTB without block if not indicated otherwise with bars (**** = p<0,0001, *** = p<0,005, ** = p<0,01 and * = p<0,05).

Journal: PLoS Pathogens

Article Title: GM1 ganglioside-independent intoxication by Cholera toxin

doi: 10.1371/journal.ppat.1006862

Figure Lengend Snippet: (A) Bar graph showing relative absorbance values from an ELISA with immobilized anti-Le X , and detection with CTB-HRP. Samples as indicated from lysates of isolated human cells (2 μg protein/ml). Each dot represents a human donor (n = 5–8). (B) CD66 or (C) CD66 and Le X expression by jejunal epithelial cells that were isolated using EDTA medium (villi) or enzymatic degradation after EDTA treatment (non-villi or crypt). Histograms from flow cytometry analyses of CTB-, G33D- and OVA-binding to the differentially enriched epithelial cells. (B) EpCAM + cells and (C) EpCAM + Le X+ cells. (D-G) Bar graph showing percent of gMFI of CTB binding to jejunal epithelial cells by pretreatment of the cells with (D) lectins, (E) sugars, (F) oligosaccharides and (G) HSA-linked oligosaccharides. Graphs show the percent of gMFI of CTB binding to the cells where 100% represents CTB staining with no blocking oligosaccharide. Each dot represents a donor in (D) n = 4–12, (E) n = 6–8, (F) n = 6–12, (G) n = 6–7. Significance was calculated using a one-way-ANOVA with Tukey correction compared to CTB without block if not indicated otherwise with bars (**** = p<0,0001, *** = p<0,005, ** = p<0,01 and * = p<0,05).

Article Snippet: Cells were then incubated for 30 min on ice with diluted biotinylated CTB (Thermo Fisher Scientific/Invitrogen, Cat. No. C34779) or biotinylated lectins (Vector Labs: PNA, Cat. B-1075; MAL-II, Cat. No. B-1265; AAL, Cat. No. B-1395) at the following concentrations: 100 μl of 10 μg/ml was added per well.

Techniques: Enzyme-linked Immunosorbent Assay, Isolation, Expressing, Flow Cytometry, Binding Assay, Staining, Blocking Assay

(A-E) C6 cells were cultured with the indicated inhibitors for 72 h followed by: (A) Staining was then performed with biotin-CTB, followed by DTAF-streptavidin. Fluorescence was measured by flow cytometry, represented here by MFI. (B) 1 h exposure to CT after which accumulated cAMP was measured by the cAMP-Glo™ luminescence assay. Luminescence signal is inversely proportional to cAMP levels. (C) As in panel A , but stained with biotin-PNA, followed by DTAF-streptavidin (D) Cell lysates were separated by PAGE and probed with biotin-PNA, biotin-CTB, or no biotinylated reagent, followed by streptavidin-peroxidase conjugate and development with chemiluminescent substrate. Equivalent amounts of protein were loaded in each lane and blots were probed with an anti-α-tubulin or anti-GAPDH antibody to confirm equivalent loading. (E) As in panel B , but brefeldin A (BFA) was added 1 h prior to CT addition and was also present during CT induction.

Journal: PLoS Pathogens

Article Title: GM1 ganglioside-independent intoxication by Cholera toxin

doi: 10.1371/journal.ppat.1006862

Figure Lengend Snippet: (A-E) C6 cells were cultured with the indicated inhibitors for 72 h followed by: (A) Staining was then performed with biotin-CTB, followed by DTAF-streptavidin. Fluorescence was measured by flow cytometry, represented here by MFI. (B) 1 h exposure to CT after which accumulated cAMP was measured by the cAMP-Glo™ luminescence assay. Luminescence signal is inversely proportional to cAMP levels. (C) As in panel A , but stained with biotin-PNA, followed by DTAF-streptavidin (D) Cell lysates were separated by PAGE and probed with biotin-PNA, biotin-CTB, or no biotinylated reagent, followed by streptavidin-peroxidase conjugate and development with chemiluminescent substrate. Equivalent amounts of protein were loaded in each lane and blots were probed with an anti-α-tubulin or anti-GAPDH antibody to confirm equivalent loading. (E) As in panel B , but brefeldin A (BFA) was added 1 h prior to CT addition and was also present during CT induction.

Article Snippet: Cells were then incubated for 30 min on ice with diluted biotinylated CTB (Thermo Fisher Scientific/Invitrogen, Cat. No. C34779) or biotinylated lectins (Vector Labs: PNA, Cat. B-1075; MAL-II, Cat. No. B-1265; AAL, Cat. No. B-1395) at the following concentrations: 100 μl of 10 μg/ml was added per well.

Techniques: Cell Culture, Staining, Fluorescence, Flow Cytometry, Luminescence Assay

(A) Representative histograms from flow cytometry analyses of CTB-, G33D- and OVA-binding to WT and KO jejunal cells (non-villi epithelial and CD45+ cells). (B) Bar graph showing CTB, G33D and OVA gMFI of non-villi jejunal epithelial cells from wt (black) and KO (gray). (C-F) Bar graphs showing percent of gMFI of non-blocked CTB binding to non-villi jejunal epithelial cells (wt black and KO gray) following pretreatment of the cells with (C) lectins or CTB with (D) sugars, (E) oligosaccharides and (F) HSA-linked oligosaccharides. Graphs show the percent of gMFI of CTB binding to the cells where 100% represents CTB staining with no blocking. (G-H) Bar graph showing intestine-animal ratio (by weight) for WT and KO mice gavaged with PBS with or without CT. (H) KO mice were fed chow with (open circles) or without (full circles) NB-DNJ for 4 weeks prior to gavage. The graphs are from pooled experiments where each dot represents one animal (n = 4–30). Significance was calculated using a one-way-ANOVA with Tukey correction (**** = p<0,0001, *** = p<0,005, ** = p<0,01 and * = p<0,05).

Journal: PLoS Pathogens

Article Title: GM1 ganglioside-independent intoxication by Cholera toxin

doi: 10.1371/journal.ppat.1006862

Figure Lengend Snippet: (A) Representative histograms from flow cytometry analyses of CTB-, G33D- and OVA-binding to WT and KO jejunal cells (non-villi epithelial and CD45+ cells). (B) Bar graph showing CTB, G33D and OVA gMFI of non-villi jejunal epithelial cells from wt (black) and KO (gray). (C-F) Bar graphs showing percent of gMFI of non-blocked CTB binding to non-villi jejunal epithelial cells (wt black and KO gray) following pretreatment of the cells with (C) lectins or CTB with (D) sugars, (E) oligosaccharides and (F) HSA-linked oligosaccharides. Graphs show the percent of gMFI of CTB binding to the cells where 100% represents CTB staining with no blocking. (G-H) Bar graph showing intestine-animal ratio (by weight) for WT and KO mice gavaged with PBS with or without CT. (H) KO mice were fed chow with (open circles) or without (full circles) NB-DNJ for 4 weeks prior to gavage. The graphs are from pooled experiments where each dot represents one animal (n = 4–30). Significance was calculated using a one-way-ANOVA with Tukey correction (**** = p<0,0001, *** = p<0,005, ** = p<0,01 and * = p<0,05).

Article Snippet: Cells were then incubated for 30 min on ice with diluted biotinylated CTB (Thermo Fisher Scientific/Invitrogen, Cat. No. C34779) or biotinylated lectins (Vector Labs: PNA, Cat. B-1075; MAL-II, Cat. No. B-1265; AAL, Cat. No. B-1395) at the following concentrations: 100 μl of 10 μg/ml was added per well.

Techniques: Flow Cytometry, Binding Assay, Staining, Blocking Assay

List of names and specifications of antibodies and lectins used in this work

Journal: The Journal of Neuroscience

Article Title: Proteoglycan IMPG2 Shapes the Interphotoreceptor Matrix and Modulates Vision

doi: 10.1523/JNEUROSCI.2994-19.2020

Figure Lengend Snippet: List of names and specifications of antibodies and lectins used in this work

Article Snippet: PNA , , N -acetylgalactosamine , 1:1000 , Vector Laboratories , B-1075.

Techniques: Plasmid Preparation